Onetime Malaria Therapy Pyrimethamine Reduces Levels of ALS-linked Protein, Study Finds

The former malaria therapy pyrimethamine reduces levels of an ALS-linked protein in the spinal fluid of patients whose disease stems from gene mutations, a Phase 1/2 clinical trial shows. The protein is SOD1. The mutations connected with amyotrophic lateral sclerosis are in the SOD1 gene that controls the protein. The…

I have a good friend who also lives with a life-threatening illness; mine is ALS, her’s is cancer. Recently we visited, and I asked how things were going. Smiling broadly, she replied, “Oh, I’m still just one banana peel away from dropping the other shoe! So, hide the bananas!” We…

Mallinckrodt has launched the Phase 2b PENNANT trial (NCT03068754) to investigate the safety and effectiveness of H.P. Acthar Gel (repository corticotropin injection) as a treatment for amyotrophic lateral sclerosis (ALS). The H.P. Acthar Gel is an experimental injectable drug that the U.S. Food and Drug Administration (FDA) has granted fast…

The U.S. Food and Drug Administration has expanded its approval of Dysport (abobotulinumtoxinA) as a  treatment for spasticity in adults from not just the upper limbs but to the lower limbs as well, according to its maker, Ipsen Biopharmaceuticals. Spasticity can affect those with amyotrophic lateral sclerosis (ALS), multiple sclerosis, cerebral…

Many people suffer from fasciculations or muscle twitching, and most of the time, it’s caused by drinking too much coffee, a lack of sleep or a trapped nerve. However, repeated episodes of fasciculations could be a sign of a neuromuscular disorder such as amyotrophic lateral sclerosis (ALS). MORE: An overview…

Stem cell transplantation in patients with amyotrophic lateral sclerosis (ALS) has the potential to be “an important alternative strategy” in treating the disease, a new study suggests. In recent decades, many advances in identifying and understanding the underlying mechanisms of ALS have been made. But those advances have not resulted in…

A new study shows that patients with amyotrophic lateral sclerosis (ALS) experience decreased oxidative metabolism during exercise, and that differences among individuals in exercise capacity matches ALS clinical heterogeneity. The study, titled, “Inefficient skeletal muscle oxidative function…

There isn’t one test that doctors can use to determine if a person has amyotrophic lateral sclerosis (ALS). Instead, doctors need to perform a series of tests to eliminate other similar neurological diseases and to arrive at an ALS diagnosis. The process can be slow, taking an average of 12 to 14 months…

The public’s interest in essential oils (EOs) — their uses, benefits, and safety — has been on the rise for several years. The most common means of using EOs is through aromatherapy, which includes having a diffuser in your home and or carrying a personal diffuser with you. You’ll find…

AveXis and REGENXBIO have signed a new licensing agreement to develop therapies for a particular form of ALS and for Rett syndrome. They already have an agreement that covers spinal muscular atrophy therapies. The form of amyotrophic lateral sclerosis that the new agreement covers is the one caused by mutations…